Who invested in Ducentis BioTherapeutics?
Ducentis BioTherapeutics's investors include Capital Cell.
Funding summaryUpdated 26 Oct 2026
$1.1Mraised across 1 round since 2017, from 1 source
Ducentis BioTherapeutics's investors include Capital Cell.
Ducentis BioTherapeutics has raised $1.1M across 1 round since 2017.
Ducentis BioTherapeutics's most recent round was a Pre-seed of $1.1M in Aug 2017.
Its most recent round, $1.1M in Aug 2017, is also its largest on record.
Ducentis BioTherapeutics's first round on record, in Aug 2017, was backed by Capital Cell.
Ducentis BioTherapeutics's latest named round is a Pre-seed, in Aug 2017.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.